BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2650877)

  • 21. Expressions of the c-Ha-ras and c-myc genes in rat liver tumors.
    Makino R; Hayashi K; Sato S; Sugimura T
    Biochem Biophys Res Commun; 1984 Mar; 119(3):1092-102. PubMed ID: 6712668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine.
    Rimoldi D; Srikantan V; Wilson VL; Bassin RH; Samid D
    Cancer Res; 1991 Jan; 51(1):324-30. PubMed ID: 1703037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The expression of oncogenes in the development of human brain].
    Sun N; Sun Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):9-12. PubMed ID: 1398634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
    Pechoux C; Chardonnet Y; Chignol MC; Noël P
    Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
    Schäfer R; Geisse S; Willecke K
    J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogene-mediated transformation of fetal rat colon in vitro.
    Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
    Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the proto-oncogenes C-H-ras and N-ras in early second trimester human fetal tissues.
    Mellersh H; Strain AJ; Hill DJ
    Biochem Biophys Res Commun; 1986 Dec; 141(2):510-6. PubMed ID: 3541935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
    Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
    Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
    Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
    Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biochemical and molecular biological aspects of stomach cancer development in human and animal].
    Khanson KP; Kalinovskiĭ VP; Novikov LB; Fedorov SN
    Vopr Med Khim; 1991; 37(6):84-8. PubMed ID: 1812623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
    Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
    J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of C-myc and C-Ha-ras oncogene expression by cell shape.
    Farrell RE; Greene JJ
    J Cell Physiol; 1992 Nov; 153(2):429-35. PubMed ID: 1385453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular oncogenes in human teratocarcinoma cell lines.
    Tesch H; Fürbass R; Casper J; Lyons J; Bartram CR; Schmoll HJ; Bronson DL
    Int J Androl; 1990 Oct; 13(5):377-88. PubMed ID: 2283183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of retinoic acid on growth and proto-oncogene expression in hamster tracheal epithelial cells.
    Niles RM; Loewy BP; Brown K
    Am J Respir Cell Mol Biol; 1990 Apr; 2(4):365-71. PubMed ID: 1691008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Proto-oncogene expression in the organs of intact adult rats].
    Novikov LB; Tlevlesov NIa; Timoshenko MG; Kalinovskiĭ VP; Fedorov SN
    Eksp Onkol; 1989; 11(3):14-7. PubMed ID: 2473875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proto-oncogene expression in mouse leukemia induced by the Mazurenko virus].
    Mazurenko NN; Seniuta NB; Gladkova TI; Mazurenko NP
    Biull Eksp Biol Med; 1988 Jan; 105(1):71-4. PubMed ID: 2827809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
    Futscher BW; Erickson LC
    Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexpression of translocated and normal c-myc oncogenes in hybrids between Daudi and lymphoblastoid cells.
    Croce CM; Erikson J; Huebner K; Nishikura K
    Science; 1985 Mar; 227(4691):1235-8. PubMed ID: 3856319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of c-myc RNA and its proteins in Daudi cells by interferon-beta.
    Jonak GJ; Friedland BK; Anton ED; Knight E
    J Interferon Res; 1987 Feb; 7(1):41-52. PubMed ID: 3295065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.